UNLIMITED TURBO LONG - UCB Share Price

7GMIB

NLBNPNL20MV9

Real-time Euronext Paris 17:30:02 30/04/2024 BST
13.48 ^EUR	+1.35%

Current month	+19.60%
1 month	+19.60%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart UCB

Latest news about UCB

UCB : Acquisition of own shares	04-26	PU
Pioneering innovation, fueling growth: UCB's commitment to delivering differentiated solutions	04-26	PU
Ex-dividend day for final dividend	04-25	FA
UCB : General Meeting of Shareholders 2024	04-25	PU

More news

Quotes 5-day view

Date	Price	Change	Volume
30/04/24	13.48	+1.35%	84
29/04/24	13.3	-1.55%	96
26/04/24	13.52	+1.43%	97
25/04/24	13.32	+6.69%	97
24/04/24	12.49	-1.96%	95

Real-time Euronext Paris

Last update April 30, 2024 at 05:30 pm

More quotes

Static data

Product type	Knock-Out ohne Stop Loss
Buy / Sell	CALL
Underlying	UCB
Issuer	BNP Paribas
	7GMIB
ISIN	NLBNPNL20MV9
Date issued	23/08/2022
Strike	58.49 €
Maturity	Unlimited
Parity	5 : 1
Emission price	3.62 €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	13.56 €
Lowest since issue	1.75 €

Company Profile

UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.

Sector

More about the company

Ratings for UCB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: UCB

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

124.6 EUR

Average target price

125.5 EUR

Spread / Average Target

+0.76%

Consensus